Updates in diabetic macular edema, diabetic retinopathy

Emerging agents and therapies in the pipeline for the treatment of diabetic retinopathy and diabetic macular edema.

Challenges commonly faced by providers for the treatment of diabetes and how to ensure patients come back for follow-up visits.

The role of DRCR.net clinical trials in guiding the management of DR/DME and a review of the safety and efficacy of anti-VEGF agents.

Approaching the practical management of proliferative and nonproliferative diabetic retinopathy (DR) and diabetic macular edema (DME) according to the ADA (American Diabetes Association) guidelines.

Experts discuss successful communication among optometrists, retina specialists, and primary care providers when treating a patient with diabetes.

A discussion on educating a patient with diabetes on disease management, including routine hemoglobin A1C screenings to optimize health, and sending a referral to a retina specialist.

Evaluating the use of OCT-A for patients with diabetes in clinical practice and whether it should become a standard of care.

The importance of imaging in a diabetes eye exam with OCT-A and widefield angiograms is examined.

Expert optometrists and ophthalmologists provide an overview of diabetic retinopathy and the standard of care for a diabetes eye exam.